Home › M&M › Filing
🔔 Get instant alerts when M&M files quarterly results on BSE Start free trial →

General Updates

Filed: 05 Nov 2026, 13:33 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q2FY27 - Consolidated revenue 115,741 Cr +26% y-y; PAT 4,588 Cr +25% y-y; RoE at 21% annualised H1 - Auto segment: 25% PAT growth; SUV revenue market share 24.3%; eSUV penetration 12.7% - Farm segment: volumes down 9%, margin pressure from commodity inflation; market share 43.4% - TechM PAT up 33% with margin expansion; MMFSL PAT up 61% - Capacity expansions on track; 5 big product launches planned by Jun 2027 - FY27 outlook: flat tractor industry, mid-high teen SUV growth, double-digit LCV growth - Proactive actions to address inflation and supply chain challenges; margin pressure expected Q3, improvement Q4
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 M&M — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add M&M to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Mahindra Mahindra Ltd

Important. The summary above is generated automatically from Mahindra Mahindra Ltd's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.